- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis ; volume:40 ; number:03 ; year:2014 ; pages:277-283
Seminars in thrombosis and hemostasis ; 40, Heft 03 (2014), 277-283
- Contributor
-
Demers, Melanie
Wagner, Denisa D.
- DOI
-
10.1055/s-0034-1370765
- URN
-
urn:nbn:de:101:1-2019011009472001905658
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Demers, Melanie
- Wagner, Denisa D.
Other Objects (12)
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
Cancer-associated adipocytes: key players in breast cancer progression
Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
Cancer-associated adipocytes: key players in breast cancer progression
Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
Cancer-associated adipocytes: key players in breast cancer progression